Droxia
Term · Oncology and biomedicine · MLC-T-ONC-002587
A drug that contains the active ingredient hydroxyurea and is used to treat certain patients with sickle cell anemia. It is also being studied in the treatment of other conditions and some types of cancer. Droxia may help keep abnormal red blood cells from forming, which may reduce the number of painful sickle cell crises and the need for blood transfusions. It is a type of antimetabolite.
| Identifier | MLC-T-ONC-002587 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002587",
"term": "Droxia",
"field": "Oncology and biomedicine",
"definition": "A drug that contains the active ingredient hydroxyurea and is used to treat certain patients with sickle cell anemia. It is also being studied in the treatment of other conditions and some types of cancer. Droxia may help keep abnormal red blood cells from forming, which may reduce the number of painful sickle cell crises and the need for blood transfusions. It is a type of antimetabolite.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/droxia/"
}
Record 6,250 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.